Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Here's a thought...
View:
Post by mercedesman on Dec 09, 2021 6:09pm

Here's a thought...

Maybe the company should set aside $ 1m of their $ 11M spare change...

Buy back 5 million shares at say . 20 to .25

Exhaust the "anonymous mystery tax loss seller"

Launch a "real" concerted US & Cdn IR /promo/marketing campaign.

Get the share price up to .50 to .75 range

Do a PP (if necessary) to replenish the coffers (although maybe not even required,  if they found a SAMI Dist. partner, or a Dialco 10% eauity partner, or Baxter coughs up  on Tranche 2, before Interim given open Label access to the "exceeding expectation" Tigris reults - at say 40 patients?, 50?  75?.

A lot less net dilution. More palatable SP.  Happier shareholders.

It's a win win !

MM
Comment by Revten on Dec 09, 2021 6:41pm
I agree MM! But in the meantime I am backing up the Truck Again!! Wow! This is getting very interesting! Thanks! Looking forward to January 2022!
Comment by BayStreetWild on Dec 09, 2021 7:18pm
Even I bought shares today. At this point it's just stupid cheap. Not sure what the logic is with the selling but if I were the company I'd put out a press release saying they don't have anything material that they haven't released. I'd buy more but with people dumping this many shares you'd almost think there was something we don't know. Seto should just start buying ...more  
Comment by Domino55 on Dec 09, 2021 7:36pm
No thank you on a press release. This is Spectral. The result of that PR would be a dime share price. we know that they can masterfully oversee the destruction of market cap but who there, in the last 15 years, has managed an upward swing of a share price? Is there anyone there capable of managing significant buying pressure? They only have 1 direction on the payroll.
Comment by BayStreetWild on Dec 09, 2021 8:18pm
That semi surprise financing was a bad move and the delay sucks but 50M market cap for a phase 3 pharma company is surreal. Unless there's some kind of meltdown in the background that we don't know about.... Maybe Seto does need to take out some sponsored BNN ads? They're not that expensive. 500 000 viewers would at least see the ad.   
Comment by mercedesman on Dec 09, 2021 10:35pm
Rev buddy !  You know what they say... in for 20 Pennies in for a pound(ing)  Don't tell too many of your friends before I get me some more.  You can buy 5% of a Phase 3, (for a couple million bucks...)   Four trick ponies Three PMAs Two FDAs  ...and  a $2B home dialysis pump !   whaddya say we combine forces and ask for....nay demand ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities